American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer

Sushil Beriwal, D. Jeffrey Demanes, Beth Erickson, Ellen Jones, Jennifer F. De Los Santos, Robert A. Cormack, Catheryn Yashar, Jason J. Rownd, Akila Viswanathan

Research output: Contribution to journalArticle

Abstract

Purpose: To present recommendations for the use of interstitial brachytherapy in patients with vaginal cancer or recurrent endometrial cancer in the vagina. Methods: A panel of members of the American Brachytherapy Society reviewed the literature, supplemented that with their clinical experience, and formulated recommendations for interstitial brachytherapy for primary or recurrent cancers in the vagina. Results: Patients with bulky disease (approximately >0.5. cm thick) should be considered for treatment with interstitial brachytherapy. The American Brachytherapy Society reports specific recommendations for techniques, target volume definition, and dose-fractionation schemes. Three-dimensional treatment planning is recommended with CT scan and/or MRI. The treatment plan should be optimized to conform to the clinical target volume and should reduce the dose to critical organs, including the rectum, bladder, urethra, and sigmoid colon. Suggested doses in combination with external beam radiation therapy and summated equivalent doses in 2. Gy fractions are tabulated. Conclusion: Recommendations are made for interstitial brachytherapy for vaginal cancer and recurrent disease in the vagina. Practitioners and cooperative groups are encouraged to use these recommendations to formulate treatment and dose-reporting policies. Such a process will result in meaningful outcome comparisons, promote technical advances, and lead to appropriate utilization of these techniques.

Original languageEnglish (US)
Pages (from-to)68-75
Number of pages8
JournalBrachytherapy
Volume11
Issue number1
DOIs
StatePublished - Jan 2012
Externally publishedYes

Fingerprint

Vaginal Neoplasms
Brachytherapy
Guidelines
Dose Fractionation
Vagina
Sigmoid Colon
Urethra
Therapeutics
Endometrial Neoplasms
Rectum
Urinary Bladder
Radiotherapy
Magnetic Resonance Imaging

Keywords

  • HDR
  • Interstitial
  • Vagina

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer. / Beriwal, Sushil; Demanes, D. Jeffrey; Erickson, Beth; Jones, Ellen; De Los Santos, Jennifer F.; Cormack, Robert A.; Yashar, Catheryn; Rownd, Jason J.; Viswanathan, Akila.

In: Brachytherapy, Vol. 11, No. 1, 01.2012, p. 68-75.

Research output: Contribution to journalArticle

Beriwal, S, Demanes, DJ, Erickson, B, Jones, E, De Los Santos, JF, Cormack, RA, Yashar, C, Rownd, JJ & Viswanathan, A 2012, 'American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer', Brachytherapy, vol. 11, no. 1, pp. 68-75. https://doi.org/10.1016/j.brachy.2011.06.008
Beriwal S, Demanes DJ, Erickson B, Jones E, De Los Santos JF, Cormack RA et al. American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer. Brachytherapy. 2012 Jan;11(1):68-75. https://doi.org/10.1016/j.brachy.2011.06.008
Beriwal, Sushil ; Demanes, D. Jeffrey ; Erickson, Beth ; Jones, Ellen ; De Los Santos, Jennifer F. ; Cormack, Robert A. ; Yashar, Catheryn ; Rownd, Jason J. ; Viswanathan, Akila. / American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer. In: Brachytherapy. 2012 ; Vol. 11, No. 1. pp. 68-75.
@article{94c19b3a4c004999af0b6faf0ae42c9b,
title = "American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer",
abstract = "Purpose: To present recommendations for the use of interstitial brachytherapy in patients with vaginal cancer or recurrent endometrial cancer in the vagina. Methods: A panel of members of the American Brachytherapy Society reviewed the literature, supplemented that with their clinical experience, and formulated recommendations for interstitial brachytherapy for primary or recurrent cancers in the vagina. Results: Patients with bulky disease (approximately >0.5. cm thick) should be considered for treatment with interstitial brachytherapy. The American Brachytherapy Society reports specific recommendations for techniques, target volume definition, and dose-fractionation schemes. Three-dimensional treatment planning is recommended with CT scan and/or MRI. The treatment plan should be optimized to conform to the clinical target volume and should reduce the dose to critical organs, including the rectum, bladder, urethra, and sigmoid colon. Suggested doses in combination with external beam radiation therapy and summated equivalent doses in 2. Gy fractions are tabulated. Conclusion: Recommendations are made for interstitial brachytherapy for vaginal cancer and recurrent disease in the vagina. Practitioners and cooperative groups are encouraged to use these recommendations to formulate treatment and dose-reporting policies. Such a process will result in meaningful outcome comparisons, promote technical advances, and lead to appropriate utilization of these techniques.",
keywords = "HDR, Interstitial, Vagina",
author = "Sushil Beriwal and Demanes, {D. Jeffrey} and Beth Erickson and Ellen Jones and {De Los Santos}, {Jennifer F.} and Cormack, {Robert A.} and Catheryn Yashar and Rownd, {Jason J.} and Akila Viswanathan",
year = "2012",
month = "1",
doi = "10.1016/j.brachy.2011.06.008",
language = "English (US)",
volume = "11",
pages = "68--75",
journal = "Brachytherapy",
issn = "1538-4721",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer

AU - Beriwal, Sushil

AU - Demanes, D. Jeffrey

AU - Erickson, Beth

AU - Jones, Ellen

AU - De Los Santos, Jennifer F.

AU - Cormack, Robert A.

AU - Yashar, Catheryn

AU - Rownd, Jason J.

AU - Viswanathan, Akila

PY - 2012/1

Y1 - 2012/1

N2 - Purpose: To present recommendations for the use of interstitial brachytherapy in patients with vaginal cancer or recurrent endometrial cancer in the vagina. Methods: A panel of members of the American Brachytherapy Society reviewed the literature, supplemented that with their clinical experience, and formulated recommendations for interstitial brachytherapy for primary or recurrent cancers in the vagina. Results: Patients with bulky disease (approximately >0.5. cm thick) should be considered for treatment with interstitial brachytherapy. The American Brachytherapy Society reports specific recommendations for techniques, target volume definition, and dose-fractionation schemes. Three-dimensional treatment planning is recommended with CT scan and/or MRI. The treatment plan should be optimized to conform to the clinical target volume and should reduce the dose to critical organs, including the rectum, bladder, urethra, and sigmoid colon. Suggested doses in combination with external beam radiation therapy and summated equivalent doses in 2. Gy fractions are tabulated. Conclusion: Recommendations are made for interstitial brachytherapy for vaginal cancer and recurrent disease in the vagina. Practitioners and cooperative groups are encouraged to use these recommendations to formulate treatment and dose-reporting policies. Such a process will result in meaningful outcome comparisons, promote technical advances, and lead to appropriate utilization of these techniques.

AB - Purpose: To present recommendations for the use of interstitial brachytherapy in patients with vaginal cancer or recurrent endometrial cancer in the vagina. Methods: A panel of members of the American Brachytherapy Society reviewed the literature, supplemented that with their clinical experience, and formulated recommendations for interstitial brachytherapy for primary or recurrent cancers in the vagina. Results: Patients with bulky disease (approximately >0.5. cm thick) should be considered for treatment with interstitial brachytherapy. The American Brachytherapy Society reports specific recommendations for techniques, target volume definition, and dose-fractionation schemes. Three-dimensional treatment planning is recommended with CT scan and/or MRI. The treatment plan should be optimized to conform to the clinical target volume and should reduce the dose to critical organs, including the rectum, bladder, urethra, and sigmoid colon. Suggested doses in combination with external beam radiation therapy and summated equivalent doses in 2. Gy fractions are tabulated. Conclusion: Recommendations are made for interstitial brachytherapy for vaginal cancer and recurrent disease in the vagina. Practitioners and cooperative groups are encouraged to use these recommendations to formulate treatment and dose-reporting policies. Such a process will result in meaningful outcome comparisons, promote technical advances, and lead to appropriate utilization of these techniques.

KW - HDR

KW - Interstitial

KW - Vagina

UR - http://www.scopus.com/inward/record.url?scp=84855996941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855996941&partnerID=8YFLogxK

U2 - 10.1016/j.brachy.2011.06.008

DO - 10.1016/j.brachy.2011.06.008

M3 - Article

C2 - 22265440

AN - SCOPUS:84855996941

VL - 11

SP - 68

EP - 75

JO - Brachytherapy

JF - Brachytherapy

SN - 1538-4721

IS - 1

ER -